About AMICUS THERAPEUTICS US, LLC
Amicus Therapeutics is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., focused on developing therapies for rare and orphan diseases. The company was founded in 2002 with a mission centered on patient advocacy and innovation in rare disease treatment.
Drug development for rare and orphan diseasesClinical trials and expanded access programsGlobal operations across multiple countries
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| GALAFOLD | Department of Veterans Affairs | $66K | |
| 3 BOTTLES OF GALAFOLD | Department of Veterans Affairs | $66K | |
| GALAFOLD 123MG - EMERGENCY RX | Department of Veterans Affairs | $63K | |
| EMERGENCY GALAFOLD FOR THE BORO VAMC PHARM | Department of Veterans Affairs | $63K | |
| GALAFOLD (MIGALASTAT) 123MG CAPS | Department of Veterans Affairs | $69K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AMICUS THERAPEUTICS US, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.